{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:39:02Z","timestamp":1758814742924},"reference-count":20,"publisher":"Danish Medical Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. The Bethesda System for Reporting Thyroid Cytopathology (BSRTC) is used to categorise thyroid fine-needle aspiration (FNA). The aim of this study was to validate the BSRTC in a consecutive cohort and to evaluate the derived management in terms of performing repeat FNA or thyroid surgery.  METHODS. Results of thyroid FNAs assessed at the Department of Pathology, Aarhus University Hospital, in the period 2016-2019 were retrieved from The Danish Pathology Registry. FNA category according to the BSRTC along with the histological diagnosis (if available) were linked to the individual patient.  RESULTS. In total, 3,669 biopsies were included from 2,873 thyroid nodules in 2,547 patients. Repeat FNA was performed in 23.6% of nodules. The majority of primary FNAs were Benign (BSRTC II; 52.4%). Non-diagnostic (ND) (BSRTC I) was found in 26.3% and BSRTC III-VI were found in 3.6-7.5%. Compared with the first with the last FNA, the frequency of Benign (BSRTC II) increased (61.3%), whereas the frequency of ND (BSRTC I) decreased (14.8%). Surgery was performed in 38.2% (n = 1,097) of nodules. The malignancy rate of 11.5% correlated positively with the BSRTC category, being 2.8% in Benign (BSRTC II) and 95.7% in Malignant (BSRTC VI).  CONCLUSIONS. The malignancy rates in the BSRTC categories were in accordance with reports from other countries. Since the BSRTC ensures a standardised and concise communication of cytopathology assessments, application of the BSRTC for thyroid nodule management in a Danish setting is recommended.  FUNDING. None.  TRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a10230677","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T06:56:58Z","timestamp":1716965818000},"page":"1-9","source":"Crossref","is-referenced-by-count":2,"title":["Validation of the Bethesda System for Reporting Thyroid Cytopathology in a Danish tertiary centre"],"prefix":"10.61409","volume":"71","author":[{"given":"Stine Horsk\u00e6r","family":"Madsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Louise","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Joop","family":"Bonnema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rolighed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine Z\u00f8ylner","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Haugen BR, Alexander EK, Bible KC et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. https:\/\/doi.org\/10.1089\/thy.2015.0020","DOI":"10.1089\/thy.2015.0020"},{"key":"ref1","unstructured":"Nygaard B, Knudsen N, Bennedb\u00e6k F et al. Knuden i thyroidea. Dansk Endokrinologisk Selskab, 2020"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Russ G, Bonnema SJ, Erdogan MF et al. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid J. 2017;6(5):225-37. https:\/\/doi.org\/10.1159\/000478927","DOI":"10.1159\/000478927"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda System for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341-6. https:\/\/doi.org\/10.1089\/thy.2017.0500","DOI":"10.1089\/thy.2017.0500"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658-65. https:\/\/doi.org\/10.1309\/AJCPPHLWMI3JV4LA","DOI":"10.1309\/AJCPPHLWMI3JV4LA"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B et al. The 2023 Bethesda System for reporting thyroid cytopathology. Thyroid. 2023;33(9):1039-44. https:\/\/doi.org\/10.1089\/thy.2023.0141","DOI":"10.1089\/thy.2023.0141"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Swan KZ, Bonnema SJ, Jespersen ML, Nielsen VE. Reappraisal of shear wave elastography as a diagnostic tool for identifying thyroid carcinoma. Endocr Connect. 2019;8(8):1195-205. https:\/\/doi.org\/10.1530\/EC-19-0324","DOI":"10.1530\/EC-19-0324"},{"key":"ref7","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, eds. WHO classification of tumours of endocrine organs. WHO classification of tumours, 4th ed., vol. 10. WHO, 2017"},{"key":"ref8","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and genetics of tumours of endocrine organs. WHO classification of tumours, 3rd ed., vol. 8. WHO, 2004"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Bjergved L, J\u00f8rgensen T, Perrild H et al. Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr study. J Clin Endocrinol Metab. 2012;97(11):4022-9. https:\/\/doi.org\/10.1210\/jc.2012-2508","DOI":"10.1210\/jc.2012-2508"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Bongiovanni M, Spitale A, Faquin WC et al. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012;56(4):333-9. https:\/\/doi.org\/10.1159\/000339959","DOI":"10.1159\/000339959"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Paajanen I, Metso S, Jaatinen P, Kholov\u00e1 I. Thyroid FNA diagnostics in a real-life setting: experiences of the implementation of the Bethesda system in Finland. Cytopathology. 2018;29(2):189-95. https:\/\/doi.org\/10.1111\/cyt.12513","DOI":"10.1111\/cyt.12513"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Avior G, Dagan O, Shochat I et al. Outcomes of the Bethesda system for reporting thyroid cytopathology: real-life experience. Clin Endocrinol (Oxf). 2021;94(3):521-7. https:\/\/doi.org\/10.1111\/cen.14341","DOI":"10.1111\/cen.14341"},{"key":"ref13","unstructured":"Larsen LV, Egset AV, Holm C et al. Thyroid fine-needle aspiration and The Bethesda Classification System. Dan Med J. 2018;65(3):A5456"},{"key":"ref14","unstructured":"Behandling af thyroideacancer. DATHYRCA-DAHANCA, 2022"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Londero SC, Krogdahl A, Bastholt L et al. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance. Thyroid. 2013;23(9):1159-64. https:\/\/doi.org\/10.1089\/thy.2012.0595","DOI":"10.1089\/thy.2012.0595"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol. 2018;44(3):307-15. https:\/\/doi.org\/10.1016\/j.ejso.2017.03.004","DOI":"10.1016\/j.ejso.2017.03.004"},{"key":"ref17","unstructured":"WHO Classification of Tumours Editorial Board. Endrocrine and neuroendocrine tumours 5th ed. vol. 10. Lyon: International Agency for Research on Cancer, 2022"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Paschke R, Cantara S, Crescenzi A et al. European Thyroid Association guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics. Eur Thyroid J. 2017;6(3):115-29. https:\/\/doi.org\/10.1159\/000468519","DOI":"10.1159\/000468519"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Durante C, Heged\u00fcs L, Czarniecka A et al. 2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. 2023;12(5): e230067. https:\/\/doi.org\/10.1530\/ETJ-23-0067","DOI":"10.1530\/ETJ-23-0067"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T08:54:49Z","timestamp":1723539289000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A10230677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.61409\/a10230677","relation":{},"ISSN":["2245-1919"],"issn-type":[{"type":"electronic","value":"2245-1919"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}